Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Trimethoprim use in early pregnancy and the risk of miscarriage: a register-based nationwide cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{23124cc34dce4f77b28996ee424f1f99,
title = "Trimethoprim use in early pregnancy and the risk of miscarriage: a register-based nationwide cohort study",
abstract = "SUMMARY The antibiotic trimethoprim acts as a folate antagonist. Since trophoblasts are very sensitive to drugs that interfere with the folic acid cycle and thereby inhibit DNA synthesis, use of trimethoprim during the first trimester could be associated with miscarriage. A nationwide cohort study including all women in Denmark with a registered pregnancy between 1997 and 2005 was conducted. We used nationwide registers to identify all women giving birth, having a record of miscarriage or induced abortion. Data on exposure to trimethoprim were obtained from the National Prescription Register. Cox proportional hazard regression analysis with exposure to trimethoprim as a time-dependent variable was used to estimate the risk of miscarriage. The adjusted hazard ratio of having a miscarriage after exposure to trimethoprim in the first trimester compared to non-exposure was 2·04 (95% confidence interval 1·43-2·91). Our results indicate that trimethoprim exposure in the first trimester is associated with a doubling of the hazard of miscarriage.",
author = "Andersen, {Jon Tr{\ae}rup} and M Petersen and E Jimenez-Solem and K Broedbaek and Andersen, {E W} and Andersen, {N L} and Shoaib Afzal and C Torp-Pedersen and Niels Keiding and Poulsen, {H E}",
year = "2012",
doi = "10.1017/S0950268812002178",
language = "English",
pages = "1--7",
journal = "Epidemiology and Infection",
issn = "0950-2688",
publisher = "Cambridge University Press",

}

RIS

TY - JOUR

T1 - Trimethoprim use in early pregnancy and the risk of miscarriage

T2 - a register-based nationwide cohort study

AU - Andersen, Jon Trærup

AU - Petersen, M

AU - Jimenez-Solem, E

AU - Broedbaek, K

AU - Andersen, E W

AU - Andersen, N L

AU - Afzal, Shoaib

AU - Torp-Pedersen, C

AU - Keiding, Niels

AU - Poulsen, H E

PY - 2012

Y1 - 2012

N2 - SUMMARY The antibiotic trimethoprim acts as a folate antagonist. Since trophoblasts are very sensitive to drugs that interfere with the folic acid cycle and thereby inhibit DNA synthesis, use of trimethoprim during the first trimester could be associated with miscarriage. A nationwide cohort study including all women in Denmark with a registered pregnancy between 1997 and 2005 was conducted. We used nationwide registers to identify all women giving birth, having a record of miscarriage or induced abortion. Data on exposure to trimethoprim were obtained from the National Prescription Register. Cox proportional hazard regression analysis with exposure to trimethoprim as a time-dependent variable was used to estimate the risk of miscarriage. The adjusted hazard ratio of having a miscarriage after exposure to trimethoprim in the first trimester compared to non-exposure was 2·04 (95% confidence interval 1·43-2·91). Our results indicate that trimethoprim exposure in the first trimester is associated with a doubling of the hazard of miscarriage.

AB - SUMMARY The antibiotic trimethoprim acts as a folate antagonist. Since trophoblasts are very sensitive to drugs that interfere with the folic acid cycle and thereby inhibit DNA synthesis, use of trimethoprim during the first trimester could be associated with miscarriage. A nationwide cohort study including all women in Denmark with a registered pregnancy between 1997 and 2005 was conducted. We used nationwide registers to identify all women giving birth, having a record of miscarriage or induced abortion. Data on exposure to trimethoprim were obtained from the National Prescription Register. Cox proportional hazard regression analysis with exposure to trimethoprim as a time-dependent variable was used to estimate the risk of miscarriage. The adjusted hazard ratio of having a miscarriage after exposure to trimethoprim in the first trimester compared to non-exposure was 2·04 (95% confidence interval 1·43-2·91). Our results indicate that trimethoprim exposure in the first trimester is associated with a doubling of the hazard of miscarriage.

U2 - 10.1017/S0950268812002178

DO - 10.1017/S0950268812002178

M3 - Journal article

C2 - 23010291

SP - 1

EP - 7

JO - Epidemiology and Infection

JF - Epidemiology and Infection

SN - 0950-2688

ER -

ID: 36469874